GET DAILY SIGNALSUnited States Antimony (UAMY) Flat Over 30 Days: Revenue -25% Drop and +10% Buyback Rally
Key Takeaways
- UAMY shares are roughly flat over the trailing 30 days, edging lower by about 2%, but that masks sharp intra-period swings tied to second-quarter results and a share-buyback announcement.
- Second-quarter revenue fell 25% year over year to $7.9 million as antimony selling prices declined about 52%, prompting management to lower its full-year 2026 revenue outlook.
- The board authorized a $100 million share repurchase program and called the stock undervalued, helping shares rally roughly 10% on the news.
- Zeolite revenue more than doubled, and Defense Logistics Agency (DLA) shipments are ramping, supporting a longer-term growth narrative.
Current Market Snapshot
United States Antimony Corporation (UAMY) traded near $5.73 in its most recent session, leaving shares essentially flat on a trailing 30-day basis after a period of unusually high volatility. The relative calm in the headline figure conceals a turbulent stretch: the stock dropped roughly 24% in a single session after second-quarter results disappointed, then partially recovered before surging about 10% when management unveiled a $100 million repurchase authorization.
From what I see, the stock sits within the critical-minerals complex, where investors are weighing a sharp decline in antimony pricing against the company's progress in building domestic supply chains, expanding zeolite output, and fulfilling government contracts. Sentiment remains split between near-term pricing pressure and the longer-term strategic value of being the only fully integrated antimony producer outside of China and Russia. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
A Closer Look at UAMY's Business and Competitive Position
United States Antimony Corporation produces and processes antimony, zeolite, and precious metals, operating facilities in Montana and Mexico and the Bear River Zeolite site in Idaho. The company markets antimony oxide, antimony metal, and antimony trisulfide for applications spanning flame retardants, batteries, bearings, and ammunition primers, while its zeolite products serve water filtration, environmental remediation, odor control, and animal nutrition markets. It also recovers gold and silver from third-party ore at its Montana facility.
A key competitive distinction is integration: UAMY describes itself as the only fully integrated antimony company in the world outside of China and Russia. Recent acquisitions of mining claims and leases in Alaska, Montana, and Ontario, Canada, are aimed at reducing reliance on third-party antimony ore and expanding the company's in-house supply chain. Investors follow the stock closely because of its exposure to a strategically important mineral with limited Western production capacity. To put the competitive landscape in context, I reviewed similar names through Tickeron’s AI Pattern Search Engine.
Recent Catalysts Driving the Stock
The dominant catalyst in recent weeks was the company's second-quarter report. Revenue declined 25% year over year to $7.9 million, well below analyst estimates, as a 26% increase in antimony pounds sold was more than offset by a roughly 52% decline in average selling prices to $13.70 per pound. Management responded by lowering 2026 revenue guidance to a range of $60 million to $75 million, down from a prior target of $125 million, citing the steep drop in antimony spot prices.
H.C. Wainwright maintained a Buy rating on the stock while trimming its price target to $9.25 from $11.75, citing balance-sheet strength and growth potential in the zeolite business. Zeolite revenue more than doubled to $1.9 million, driven by cattle-nutrition demand and broader distribution. Separately, the company reported its first DLA shipments of roughly 82,000 pounds against approximately $57 million in cumulative orders, with additional deliveries expected to contribute to third- and fourth-quarter revenue.
The most recent positive catalyst came when the board authorized a repurchase program of up to $100 million of common stock. Chairman and CEO Gary Evans said the board determined the shares were undervalued after reviewing projects across the U.S., Canada, and Mexico, a signal that helped the stock rebound by roughly 10% in a single session.
2026 Outlook and What Investors Should Watch
Looking ahead, the trajectory of antimony pricing remains the single most important variable for UAMY, given its direct effect on revenue and margins. Management has indicated it expects prices to stay near recent depressed levels, so execution on volume growth and cost discipline will be central to the 2026 story. Investors will also monitor progress toward a stated milestone: the company projects that 2026 will be the first year it begins using ore mined from its own operations to fulfill contracted customer needs, a shift executives say should improve margins and supply certainty.
Other factors to watch include the pace of DLA deliveries against the company's cumulative orders, the ramp-up of the Thompson Falls smelter expansion in Montana, and continued growth in the zeolite segment. Balance-sheet liquidity, reported at roughly $62 million in cash and U.S. Treasuries, provides a cushion, but the company remains unprofitable and reported negative operating cash flow in the first half of 2026. Commodity-price risk, government policy toward critical minerals, and execution on capital-intensive projects represent the key uncertainties heading into the remainder of the year.
Exploring Tickeron AI Tools for Trading Ideas
In my research process, I frequently turn to Tickeron’s Trending AI Robots page to review curated selections of AI-driven trading bots. It highlights top-performing and relevant strategies for stocks like UAMY, spanning short-term momentum models to longer-horizon trend-following systems. This helps me compare methodologies and identify approaches that align with current market conditions before committing capital.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
UAMY in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 12, 2026
UAMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where UAMY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UAMY's RSI Indicator exited the oversold zone, 19 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for UAMY just turned positive on October 22, 2026. Looking at past instances where UAMY's MACD turned positive, the stock continued to rise in 43 of 54 cases over the following month. The odds of a continued upward trend are 80%.
Following a +3.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where UAMY advanced for three days, in 203 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UAMY as a result. In 78 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAMY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for UAMY entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UAMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. UAMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.464) is normal, around the industry mean (6.859). P/E Ratio (-22.923) is within average values for comparable stocks, (-0.318). UAMY's Projected Growth (PEG Ratio) (9.440) is very high in comparison to the industry average of (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (17.241) is also within normal values, averaging (283.864).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a producer of antimony products
Industry OtherMetalsMinerals
Advertisement